Showing results (91-100 of 163) with videos related to
Sort By:
Pageof 17
Molecular and Clinical Oncology|December 15, 2018
<i>KRAS</i> mutation and DNA repair and synthesis genes in non-small-cell lung cancerVienna Ludovini, Biagio Ricciuti, Francesca R Tofanetti, et al.Anticancer Research|May 29, 2008
Taxanes and gemcitabine doublets in the management of HER-2 negative metastatic breast cancer: towards optimization of association and scheduleGiulio Metro, Alessandra Fabi, Michelangelo Russillo, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2011
HER2 protein and gene variation between primary and metastatic breast cancer: significance and impact on patient careAlessandra Fabi, Anna Di Benedetto, Giulio Metro, et al.Lung Cancer (Amsterdam, Netherlands)|September 24, 2015
Clinical impact of sequential treatment with ALK-TKIs in patients with advanced ALK-positive non-small cell lung cancer: Results of a multicenter analysisRita Chiari, Giulio Metro, Daniela Iacono, et al.Tumori|July 3, 2019
Treatment of metastatic non-small cell lung cancer: 2018 guidelines of the Italian Association of Medical Oncology (AIOM)Francesco Facchinetti, Sara Pilotto, Giulio Metro, et al.Drugs in Context|August 17, 2022
Advanced non-small-cell lung cancer: how to manage <i>EGFR</i> and <i>HER2</i> exon 20 insertion mutation-positive diseaseGiulio Metro, Andrea De Giglio, Biagio Ricciuti, et al.Journal of Experimental & Clinical Cancer Research : CR|January 20, 2011
Brain metastases from solid tumors: disease outcome according to type of treatment and therapeutic resources of the treating centerAlessandra Fabi, Alessandra Felici, Giulio Metro, et al.Cancer Chemotherapy and Pharmacology|April 7, 2011
Carboplatin plus pemetrexed for platinum-pretreated, advanced non-small cell lung cancer: a retrospective study with pharmacogenetic evaluationGiulio Metro, R Chiari, M Mare, et al.Clinical Lung Cancer|May 19, 2015
Outcomes of Platinum-Sensitive Small-Cell Lung Cancer Patients Treated With Platinum/Etoposide Rechallenge: A Multi-Institutional Retrospective AnalysisGiovenzio Genestreti, Marcello Tiseo, Hirotsugu Kenmotsu, et al.Ecancermedicalscience|October 6, 2015
miRNAs and resistance to EGFR-TKIs in EGFR-mutant non-small cell lung cancer: beyond 'traditional mechanisms' of resistanceBiagio Ricciuti, Carmen Mecca, Matteo Cenci, et al.Pageof 17